Table 1.
Clinical characteristics and demographics of patients included in the study.
| Characteristic COVID-19 Study Population (n = 156) | |
|---|---|
| Age, median IQR) | 50.5 (40–59) |
| Male sex N (%) | 93 (59.6) |
| Chronic Medical Condition | |
| Hypertension N (%) | 49 (31.4) |
| Congestive heart failure N (%) | 6 (3.8) |
| Coronary artery disease N (%) | 12 (7.6) |
| Prior stroke N (%) | 6 (3.8) |
| Type 2 diabetes mellitus (%) | 25 (16) |
| Obesity N (%) | 22 (14.1) |
| Cancer (solid or hematological) | 8 (5.1) |
| Chronic liver disease N (%) | 7 (4.4) |
| Chronic kidney disease N (%) | 3 (1.9) |
| Asthma or other chronic respiratory diseases N (%) | 7 (4.4) |
| Systemic inflammatory diseases N (%) | 1 (0.6) |
| Other immunosuppression conditions N (%) | 2 (1.2) |
| Duration of Symptoms at Inclusion in the Study, Median (IQR) | |
| Disease severity | 16 (10–22) |
| Mild N (%) | 62 (39.7%) |
| Moderate N (%) | 53 (33.9%) |
| Severe N (%) | 41 (26.2%) |